Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF)

European Journal of Heart Failure

Volumn 10, Issue 9, 2008, Pages 907-916

  Braunschweig, Frieder ^a   Ford, Ian ^b   Conraads, Viviane ^c   Cowie, Martin R ^d   Jondeau, Guillaume ^e   Kautzner, Josef ^f   Lunati, Maurizio ^g   Munoz Aguilera, Roberto ^h   Man Yu, Cheuk ⁱ   Marijianowski, Monique ^j   Borggrefe, Martin ^k   van Veldhuisen, Dirk J ^l  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e BICHAT HOSPITAL   (France)

^f INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^g AO Niguarda Cà Granda ^*  (Italy)

^h HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

ⁱ CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^j MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^k UNIVERSITY OF HEIDELBERG   (Germany)

^l UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

more..

Author keywords

Bioimpedance; Cardiac resynchronization; Congestive heart failure; DOT HF trial; Implantable defibrillator; Monitoring

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE; HEART FAILURE; HOSPITALIZATION; HUMAN; IMPEDANCE; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ALGORITHMS; CARDIAC PACING, ARTIFICIAL; CARDIOGRAPHY, IMPEDANCE; CHRONIC DISEASE; DATA INTERPRETATION, STATISTICAL; DEFIBRILLATORS, IMPLANTABLE; ENDPOINT DETERMINATION; FEMALE; HEART FAILURE; HUMANS; MALE; MONITORING, AMBULATORY; PULMONARY EDEMA; RESEARCH DESIGN;

EID: 51649129250     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.06.016     Document Type: Article

References (46)

1. Fonarow G.C. The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 4 Suppl 7 (2003) S21-S30
2. Stewart S., MacIntyre K., MacLeod M.M., Bailey A.E., Capewell S., and McMurray J.J. Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak?. Eur Heart J 22 3 (2001) 209-217
3. Cleland J.G., Gemmell I., Khand A., and Boddy A. Is the prognosis of heart failure improving?. Eur J Heart Fail 1 3 (1999) 229-241
4. Cowie M.R., Wood D.A., Coats A.J., et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart (British Cardiac Society) 83 5 (2000) 505-510
5. Cleland J.G., Swedberg K., Follath F., et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24 5 (2003) 442-463
6. Krumholz H.M., Parent E.M., Tu N., et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 157 1 (1997) 99-104
7. McMurray J.J., Teerlink J.R., Cotter G., et al. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA 298 17 (2007) 2009-2019
8. Haldeman G.A., Croft J.B., Giles W.H., and Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 137 2 (1999) 352-360
9. Solomon S.D., Dobson J., Pocock S., et al. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 116 13 (2007) 1482-1487
10. Konstam M.A., Gheorghiade M., Burnett Jr. J.C., et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297 12 (2007) 1319-1331
11. O'Connell J.B. The economic burden of heart failure. Clin Cardiol 23 3 Suppl (2000) III6-III10
12. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 11 (2005) 1115-1140
13. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 Guideline Update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 112 12 (2005) e154-e235
14. Stevenson L.W., and Perloff J.K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261 6 (1989) 884-888
15. Nohria A., Mielniczuk L.M., and Stevenson L.W. Evaluation and monitoring of patients with acute heart failure syndromes. Am J Cardiol 96 6A (2005) 32G-40G
16. Lewin J., Ledwidge M., O'Loughlin C., McNally C., and McDonald K. Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis?. Eur J Heart Fail 7 6 (2005) 953-957
17. Adamson P.B., Magalski A., Braunschweig F., et al. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 41 4 (2003) 565-571
18. Komajda M., Lapuerta P., Hermans N., et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 26 16 (2005) 1653-1659
19. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 21 (2004) 2140-2150
20. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 15 (2005) 1539-1549
21. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Eng J Med 352 3 (2005) 225-237
22. Rivero-Ayerza M., Theuns D.A., Garcia-Garcia H.M., Boersma E., Simoons M., and Jordaens L.J. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J 27 22 (2006) 2682-2688
23. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Eng J Med 346 24 (2002) 1845-1853
24. Freemantle N., Tharmanathan P., Calvert M.J., Abraham W.T., Ghosh J., and Cleland J.G. Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction - a systematic review and meta-analysis. Eur J Heart Fail 8 4 (2006) 433-440
25. Wang L., Lahtinen S., Lentz L., et al. Feasibility of using an implantable system to measure thoracic congestion in an ambulatory chronic heart failure canine model. Pacing Clin Electrophysiol 28 5 (2005) 404-411
26. Yu C.M., Wang L., Chau E., et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 112 6 (2005) 841-848
27. Vollmann D., Nagele H., Schauerte P., et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J. 28 15 (2007) 1835-1840
28. Maines M., Catanzariti D., Cemin C., Vaccarini C., and Vergara G. Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: a case-control study. J Interv Card Electrophysiol 19 3 (2007) 201-207
29. Bourge R.C., Abraham W.T., Adamson P.B., et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 51 11 (2008) 1073-1079
30. Adamson P.B., Conti J.B., Smith A.L., et al. Reducing events in patients with chronic heart failure (REDUCEhf) study design: continuous hemodynamic monitoring with an implantable defibrillator. Clin Cardiol 30 11 (2007) 567-575
31. Hjalmarson A. Significance of reduction in heart rate in cardiovascular disease. Clin Cardiol 21 12 Suppl 2 (1998) II3-II7
32. Lechat P., Hulot J.S., Escolano S., et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 103 10 (2001) 1428-1433
33. Fantoni C., Raffa S., Regoli F., et al. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J Am Coll Cardiol 46 10 (2005) 1875-1882
34. Nolan J., Batin P.D., Andrews R., et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 98 15 (1998) 1510-1516
35. Adamson P.B., Kleckner K.J., VanHout W.L., Srinivasan S., and Abraham W.T. Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 108 3 (2003) 266-269
36. Braunschweig F., Mortensen P.T., Gras D., et al. Monitoring of physical activity and heart rate variability in patients with chronic heart failure using cardiac resynchronization devices. Am J Cardiol 95 9 (2005) 1104-1107
37. Adamson P.B., Smith A.L., Abraham W.T., et al. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 110 16 (2004) 2389-2394
38. Jaarsma T., van der Wal M.H., Lesman-Leegte I., et al. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med 168 3 (2008) 316-324
39. Cleland J.G., Louis A.A., Rigby A.S., Janssens U., and Balk A.H. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol 45 10 (2005) 1654-1664
40. Schoenfeld M.H., Compton S.J., Mead R.H., et al. Remote monitoring of implantable cardioverter defibrillators: a prospective analysis. Pacing Clin Electrophysiol 27 6 Pt 1 (2004) 757-763
41. Vardas P.E., Auricchio A., Blanc J.J., et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association. Eur Heart J 28 18 (2007) 2256-2295
42. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 27 17 (2006) 2099-2140
43. Rector T.S., Kubo S.H., and Cohn J.H. Patients self-assessment of their heart failure: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Fail 3 (1987) 198-209
44. EuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group. Health policy (Amsterdam, Netherlands) 16 3 (1990) 199-208
45. Franciosa J.A., Taylor A.L., Cohn J.N., et al. African-American heart failure trial (A-HeFT): rationale, design, and methodology. J Card Fail 8 3 (2002) 128-135
46. Prentice R.L., Williams B.J., and Peterson A.V. On the regression analysis of multivariate failure time data. Biometrica (1981) 373-379